https://www.contractpharma.com/contents/view_online-exclusives/2023-02-06/ceo-spotlight-pierre-luzeau-on-seqens-us-rd-lab-investment/
https://www.wavelengthpharma.com/2021/12/17/seqens-acquisition-and-merger/
https://www.wavelengthpharma.com/2021/08/26/sk-capital-partners-to-acquire-seqens-and-merge-wavelength-pharmaceuticals/
https://www.wavelengthpharma.com/2021/08/16/wavelength-pharmaceuticals-signs-collaboration-agreement-tikun-olam-cannbit-development-manufacturing-marketing-pharma-grade-cgmp-cannabis-based-active-pharmaceutical-ingredients-api/
https://www.wavelengthpharma.com/2021/06/09/biocatalysis-an-indispensable-tool-for-api-synthesis/
https://endpts.com/israeli-api-maker-wavelength-buys-up-majority-stake-in-indian-firm-making-drug-starting-materials-and-intermediates/
https://www.pharmacompass.com/pdf/news/wavelength-pharmaceuticals-further-strengthens-its-global-supply-chain-with-acquisition-of-vanamali-organics-1613647287.pdf
https://www.pharmtech.com/view/hpapi-complexity-prompts-new-delivery-mechanisms
https://www.contractpharma.com/issues/2020-09-01/view_features/production-scale-up-to-meet-covid-19-demand/